echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Coatings News > Resin News > Haixing stopped production, causing epichlorohydrin to rise, epoxy resin and bisphenol A still lie flat

    Haixing stopped production, causing epichlorohydrin to rise, epoxy resin and bisphenol A still lie flat

    • Last Update: 2022-04-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Since 2022, the trend of the epichlorohydrin market has basically fluctuated in a narrow range of 17,500-19,500 yuan / ton.


    However, the news that Jiangsu Haixing unexpectedly stopped production, the market speculation was ignited by coating online coatingol.


    Haixing has stopped production this time due to environmental problems, and it is expected that it will take a long time to restart


    Bisphenol A is basically in a sideways state, and the price of 16,500 yuan / ton has lasted for more than a week


    There is no shortage of stock in the market.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.